Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
VRAX
VRAX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VRAX News
Virax Biolabs Closes $5 Million Private Placement to Extend Cash Runway
Dec 04 2025
PRnewswire
Virax Biolabs Secures $5 Million Funding to Extend Cash Runway into 2028
Dec 04 2025
Newsfilter
UiPath Shares Rise Approximately 9%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 04 2025
Benzinga
Virax Biolabs Announces $5 Million Private Placement Deal
Dec 04 2025
NASDAQ.COM
Virax Biolabs (VRAX) Shares Decline in After-Hours Trading After 75% Surge
Dec 04 2025
Benzinga
Virax Biolabs Secures $5 Million in Private Placement for 12.5 Million Shares
Dec 03 2025
PRnewswire
Virax Biolabs Secures $5 Million by Issuing 12.5 Million Shares at $0.40 Each
Dec 03 2025
Newsfilter
US Stocks Show Varied Performance; Dollar Tree Reports Positive Earnings
Dec 03 2025
Benzinga
Virax Biolabs Advances PAIS Diagnostic Technology, Data Release Expected in 2026
Dec 03 2025
PRnewswire
EXCLUSIVE: Virax Biolabs Signs Research Agreement to Enhance Long COVID Diagnostic Research
Aug 26 2025
Yahoo Finance
How an obscure SEC proposal could boost listings on European stock exchanges
Aug 05 2025
CNBC
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
Jul 18 2025
Newsfilter
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating
Mar 31 2025
Benzinga
Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes
Mar 18 2025
PRnewswire
Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting
Mar 13 2025
Newsfilter
WHO maintains public health emergency alert on mpox
Feb 27 2025
SeekingAlpha
Show More News
